Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 3
1963 2
1965 6
1966 2
1968 3
1969 2
1970 1
1971 4
1972 7
1973 11
1974 4
1975 6
1976 5
1977 3
1978 5
1979 7
1980 5
1981 12
1982 11
1983 16
1984 14
1985 13
1986 23
1987 17
1988 15
1989 15
1990 17
1991 5
1992 24
1993 20
1994 25
1995 10
1996 30
1997 11
1998 21
1999 12
2000 15
2001 10
2002 9
2003 14
2004 13
2005 12
2006 5
2007 9
2008 12
2009 11
2010 18
2011 18
2012 14
2013 15
2014 21
2015 26
2016 18
2017 20
2018 28
2019 18
2020 13
2021 32
2022 24
2023 20
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

742 results

Results by year

Filters applied: . Clear all
Page 1
NKG2A and HLA-E define an alternative immune checkpoint axis in bladder cancer.
Salomé B, Sfakianos JP, Ranti D, Daza J, Bieber C, Charap A, Hammer C, Banchereau R, Farkas AM, Ruan DF, Izadmehr S, Geanon D, Kelly G, de Real RM, Lee B, Beaumont KG, Shroff S, Wang YA, Wang YC, Thin TH, Garcia-Barros M, Hegewisch-Solloa E, Mace EM, Wang L, O'Donnell T, Chowell D, Fernandez-Rodriguez R, Skobe M, Taylor N, Kim-Schulze S, Sebra RP, Palmer D, Clancy-Thompson E, Hammond S, Kamphorst AO, Malmberg KJ, Marcenaro E, Romero P, Brody R, Viard M, Yuki Y, Martin M, Carrington M, Mehrazin R, Wiklund P, Mellman I, Mariathasan S, Zhu J, Galsky MD, Bhardwaj N, Horowitz A. Salomé B, et al. Among authors: hammer c. Cancer Cell. 2022 Sep 12;40(9):1027-1043.e9. doi: 10.1016/j.ccell.2022.08.005. Cancer Cell. 2022. PMID: 36099881 Free PMC article.
Germline variants associated with toxicity to immune checkpoint blockade.
Groha S, Alaiwi SA, Xu W, Naranbhai V, Nassar AH, Bakouny Z, El Zarif T, Saliby RM, Wan G, Rajeh A, Adib E, Nuzzo PV, Schmidt AL, Labaki C, Ricciuti B, Alessi JV, Braun DA, Shukla SA, Keenan TE, Van Allen E, Awad MM, Manos M, Rahma O, Zubiri L, Villani AC, Fairfax B, Hammer C, Khan Z, Reynolds K, Semenov Y, Schrag D, Kehl KL, Freedman ML, Choueiri TK, Gusev A. Groha S, et al. Among authors: hammer c. Nat Med. 2022 Dec;28(12):2584-2591. doi: 10.1038/s41591-022-02094-6. Epub 2022 Dec 16. Nat Med. 2022. PMID: 36526723 Free PMC article.
Memory B Cells Activate Brain-Homing, Autoreactive CD4+ T Cells in Multiple Sclerosis.
Jelcic I, Al Nimer F, Wang J, Lentsch V, Planas R, Jelcic I, Madjovski A, Ruhrmann S, Faigle W, Frauenknecht K, Pinilla C, Santos R, Hammer C, Ortiz Y, Opitz L, Grönlund H, Rogler G, Boyman O, Reynolds R, Lutterotti A, Khademi M, Olsson T, Piehl F, Sospedra M, Martin R. Jelcic I, et al. Among authors: hammer c. Cell. 2018 Sep 20;175(1):85-100.e23. doi: 10.1016/j.cell.2018.08.011. Epub 2018 Aug 30. Cell. 2018. PMID: 30173916 Free PMC article.
[Treatment-resistant nodular scleritis].
Hübner L, Mardin CY, Held J, Tappe D, Hammer CM, Bergua A. Hübner L, et al. Among authors: hammer cm. Ophthalmologie. 2023 Jan;120(1):72-75. doi: 10.1007/s00347-022-01597-4. Epub 2022 Mar 8. Ophthalmologie. 2023. PMID: 35258688 German. No abstract available.
Nutrition of Broodmares.
Robles M, Hammer C, Staniar B, Chavatte-Palmer P. Robles M, et al. Among authors: hammer c. Vet Clin North Am Equine Pract. 2021 Apr;37(1):177-205. doi: 10.1016/j.cveq.2021.01.001. Vet Clin North Am Equine Pract. 2021. PMID: 33820606 Review.
Hallmarks of Resistance to Immune-Checkpoint Inhibitors.
Karasarides M, Cogdill AP, Robbins PB, Bowden M, Burton EM, Butterfield LH, Cesano A, Hammer C, Haymaker CL, Horak CE, McGee HM, Monette A, Rudqvist NP, Spencer CN, Sweis RF, Vincent BG, Wennerberg E, Yuan J, Zappasodi R, Lucey VMH, Wells DK, LaVallee T. Karasarides M, et al. Among authors: hammer c. Cancer Immunol Res. 2022 Apr 1;10(4):372-383. doi: 10.1158/2326-6066.CIR-20-0586. Cancer Immunol Res. 2022. PMID: 35362046 Free PMC article.
Field Epidemiology: Fit for the future.
Hahné S, Hammer C, Tostmann A, Whelan J, Williams C. Hahné S, et al. Among authors: hammer c. Euro Surveill. 2023 Sep;28(36):2300347. doi: 10.2807/1560-7917.ES.2023.28.36.2300347. Euro Surveill. 2023. PMID: 37676144 Free PMC article.
MiDAS-Meaningful Immunogenetic Data at Scale.
Migdal M, Ruan DF, Forrest WF, Horowitz A, Hammer C. Migdal M, et al. Among authors: hammer c. PLoS Comput Biol. 2021 Jul 6;17(7):e1009131. doi: 10.1371/journal.pcbi.1009131. eCollection 2021 Jul. PLoS Comput Biol. 2021. PMID: 34228721 Free PMC article.
Systematic discovery of neoepitope-HLA pairs for neoantigens shared among patients and tumor types.
Gurung HR, Heidersbach AJ, Darwish M, Chan PPF, Li J, Beresini M, Zill OA, Wallace A, Tong AJ, Hascall D, Torres E, Chang A, Lou K', Abdolazimi Y, Hammer C, Xavier-Magalhães A, Marcu A, Vaidya S, Le DD, Akhmetzyanova I, Oh SA, Moore AJ, Uche UN, Laur MB, Notturno RJ, Ebert PJR, Blanchette C, Haley B, Rose CM. Gurung HR, et al. Among authors: hammer c. Nat Biotechnol. 2023 Oct 19. doi: 10.1038/s41587-023-01945-y. Online ahead of print. Nat Biotechnol. 2023. PMID: 37857725
742 results